FORMULATION DEVELOPMENT AND IN VITRO CHARACTERIZATION OF TERNARY HYDROTROPIC SOLID DISPERSIONS OF ACECLOFENAC

Authors

  • PRASENJIT SARKAR Department of Pharmaceutical Technology, Birbhum Pharmacy School, Bandhersole, Hetampur, Sadaipur, Birbhum, West Bengal, India. https://orcid.org/0000-0002-6864-967X
  • SUTAPA BISWAS MAJEE Department of Pharmaceutical Technology, Division of Pharmaceutics, NSHM Knowledge Campus, Kolkata-Group of Institutions, Kolkata, West Bengal, India. https://orcid.org/0000-0001-6325-0339

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i9.45158

Keywords:

Carrier, Crospovidone, Hydrotrope, Skimmed milk, Solid dispersion, Solubility enhancement, Superdisintegrant, Ternary mixture, urea

Abstract

Objective: Among the various strategies employed to enhance solubility, dissolution, and bioavailability of poorly soluble drugs in vivo, formulation of solid dispersion (SD) using hydrophilic and/or water-soluble carriers with varying physicochemical characteristics seems to be a developable, economically viable and easy option. The goal of the present study was to explore the possibilities of skimmed milk (SKM)-urea (U)-crospovidone (CP) as a novel ternary mixture of carrier-hydrotrope-superdisintegrant in SD of poorly water-soluble aceclofenac (ACF).

Methods: Compatibility of ACF and ternary mixture of SKM-U-CP was confirmed by FTIR spectroscopic analysis. SDs of ACF-SKM, ACF-SKM-U and ternary hydrotropic SD, and ACF-SKM-U-CP were prepared in varying ratios of 1:1–1: 5 for ACF-SKM; 1:5:0.5, 1:5:0.75, and 1:5:1 for ACF-SKM-U and 1:5:0.75:0.25–1:5:0.75:1 for ACF-SKM-U-CP by solvent evaporation technique and were characterized by their solubility enhancement (compared to pure drug) at 25°C and drug dissolution profiles in double-distilled water and phosphate buffer (pH 6.8).

Results: Based on solubility enhancement data (82.10% and 44.06%) and maximum cumulative percentage drug release data (88.45% in 9 min and 76.18% in 60 s) in double-distilled water and phosphate buffer, respectively, ACF-SKM-U(1:5:0.75) was found to the best among ACF-SKM and ACF-SKM-U SDs which were used for studying the effect of adding CP as superdisintigrant. ACF: SKM: U: CP (1: 5: 0.75: 0.50) exhibited maximum solubility enhancement of 83.92% and 49.69% and cumulative percentage release of 98.55 % in 9 min and 85.67 % in 60 s in double-distilled water and buffer, respectively.

Conclusion: Therefore, the novel ternary mixture of SKM-U-CP has demonstrated marginal superiority over SKM as carrier for from hydrotropic SDs of ACF.

Downloads

Download data is not yet available.

References

SSavjani KT, Gajjar AK, Savjani JK. Drug solubility: Importance and enhancement techniques. ISRN Pharm 2012;2012:195727.

Narayan K. Technologies to improve the solubility, dissolution and bioavailability of poorly soluble drugs. J Anal Pharm Res 2018;7:44-50.

Tekade AR, Yadav JN. A review on solid dispersion and carriers used therein for solubility enhancement of poorly water soluble drugs. Adv Pharm Bull 2020;10:359-69. doi: 10.34172/apb.2020.044, PMID 32665894

Maheshwari RK, Indurkhya A. Novel application of mixed hydrotropic solubilisation technique in the formulation and evaluation of hydrotropic solid dispersion of aceclofenac. Asian J Pharm 2010;4:235-8. doi: 10.4103/0973-8398.72124

Gulia R, Singh S, Sharma N, Arora S. Hydrotropic solid dispersions: A robust application to undertake solubility challenge. Plant Arch 2020;20:3279-84.

Patel DM, Patel SP, Patel CN. Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion. Int J Pharm Investig 2014;4:174-82. doi: 10.4103/2230-973X.143116, PMID 25426438

Ha ES, Baek IH, Cho W, Hwang SJ, Kim MS. Preparation and evaluation of solid dispersion of atorvastatin calcium with soluplus® by spray drying technique. Chem Pharm Bull (Tokyo) 2014;62:545-51. doi: 10.1248/cpb.c14-00030, PMID 24881660

Suthar RM, Chotai NP, Shah DD. Formulation and evaluation of fast dissolving tablets of ondansetron by solid dispersion in superdisintegrants. Indian J Pharm Educ Res 2013;47:49-55. doi: 10.5530/ijper.47.3.8

Suthar RM, Chotai NP, Patel HK, Patel SR, Shah DD, Jadeja MB. In vitro dissolution enhancement of ondansetron by solid dispersion in superdisintegrants. Dissolution Technol 2013;20:34-8. doi: 10.14227/ DT200413P34

Mohanachandran PS, Sindhumol PG, Kiran TS. Superdisintegrants: An overview. Int J Pharm Sci Rev Res 2011;6:105-9.

Chaulang G, Patel P, Hardikar S, Kelkar M, Bhosale A, Bhise S. Formulation and evaluation of solid dispersions of furosemide in sodium starch glycolate. Trop J Pharm Res 2009;8:43-51. doi: 10.4314/ tjpr.v8i1.14711

Nagarsenker MS, Meshram RN, Ramprakash G. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: Enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J Pharm Pharmacol 2000;52:949-56. doi: 10.1211/0022357001774831, PMID 11007065

Sapkal SB, Shinde SA. Solid dispersion of valsartan for solubility improvement using β-cyclodextrin. MOJ BioequivAvailab 2018;5:313-9.

Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603-16. doi: 10.1016/j.addr.2007.05.010, PMID 17619064

Bighley LD, Berge SM, Monkhouse DC. Salt forms of drugs and absorption. Encyclopaedia Pharm Technol 1996;13:453-99.

Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, et al. An integrated approach to the selection of optimal salt form for a new drug candidate. Int J Pharm 1994;105:209-17. doi: 10.1016/0378- 5173(94)90104-X

Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig 2012;2:12-7. doi: 10.4103/2230-973X.96921, PMID 23071955

Vasconcelos TF, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068-75. doi: 10.1016/j.drudis.2007.09.005, PMID 18061887

Kaur J, Aggarwal G, Singh G, Rana AC. Improvement of drug solubility using solid dispersion. Int J Pharm Pharm Sci 2012;4:47-53.

Alshehri S, Imam SS, Hussain A, Altamimi MA, Alruwaili NK, Alotaibi F, et al. Potential of solid dispersions to enhance solubility, bioavailability and therapeutic efficacy of poorly water-soluble drugs: Newer formulation techniques, current marketed scenario and patents. Drug Deliv 2020;27:1625-43. doi: 10.1080/10717544.2020.1846638, PMID 33207947

Altamimi MA, Elzayat EM, Qamar W, Alshehri SM, Sherif AY, Haq N, et al. Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion. Saudi Pharm J 2019;27:629-36. doi: 10.1016/j. jsps.2019.03.004, PMID 31297016

Alshehri S, Shakeel F, Elzayat E, Almeanazel O, Altamimi M, Shazly G, et al. Rat palatability, pharmacodynamics effect and bioavailability of mefenamic acid formulations utilizing hot-melt extrusion technology. Drug Dev Ind Pharm 2019;45:1610-6. doi: 10.1080/03639045.2019.1645161, PMID 31311329

Soni GC, Chaudhary PD, Sharma PK. Solubility enhancement of poorly water soluble drug aceclofenac. Indian J Pharm Pharmacol 2016;3:139-45. doi: 10.5958/2393-9087.2016.00030.3

Tiwari BK, Gupta V, Jain A, Pandey A. Enhancement of solubility of aceclofenac by using different solubilization technique. Int J Pharm Life Sci 2011;2:620-4.

Semalty A, Semalty M, Rawat BS, Singh D, Rawat MS. Development and evaluation of pharmacosomes of aceclofenac. Indian J Pharm Sci 2010;72:576-81. doi: 10.4103/0250-474X.78523, PMID 21694988

Malik MZ, Ahmad M, Minhas MU, Munir A. Solubility and permeability studies of aceclofenac in different oils. Trop J Pharm Res 2014;13:327-30. doi: 10.4314/tjpr.v13i3.2

Shakeel F, Ramadan W, Shafiq S. Solubility and dissolution improvement of aceclofenac using different nanocarriers. J BioequivAvailab 2009;1:39-43.

Samal HB, Debata J, Kumar NN, Sneha S, Patra PK. Solubility and dissolution improvement of aceclofenacusing β-cyclodextrin. Int J Drug Dev Res 2012;4:326-33.

Choudhary A, Rana AC, Aggarwal G, Kumar V, Zakir F. Development and characterization of anatorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharmacol Sin B 2012;2:421-8. doi: 10.1016/j.apsb.2012.05.002

Moideen MM, Alqahtani A, Venkatesan K, Ahmad F, Krisharaju K, Gayasuddin M, et al. Application of the box-behnken design for the production of soluble curcumin: Skimmed milk powder inclusion complex for improving the treatment of colorectal cancer. Food Sci Nutr 2020;8:6643-59.

Sonar PA, Behera AL, Banerjee SK, Gaikwad DD, Harer SL. Preparation and characterization of simvastatin solid dispersion using skimmed milk. Drug Dev Ind Pharm 2015;41:22-7. doi: 10.3109/03639045.2013.845836, PMID 24160569

Sharma N, Jain N, Sudhakar CK, Jain S. Formulation and evaluation of gastro retentive floating tablets containing cefpodoxime proxetil solid dispersions. Int J Curr Pharm Res 2012;4:82-7.

Paul AD, Vinay J, Rajyalakshmi KG, Prasad PV. Formulation design for poorly water-soluble drug by using solid dispersion of telmisartan for solubility and dissolution rate enhancement. Glob J Pharm Sci 2019;7:1-11

Sapkal S, Narkhede M, Babhulkar M, Mehetre G, Rathi A. Natural polymers: Best carriers for improving bioavailability of poorly water soluble drugs in solid dispersions. Marmara Pharm J 2013;2:65-72.

Nikghalb LA, Singh G, Singh G, Kahkeshan KF. Solid dispersion: Methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci 2012;2:170-5.

Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145-53. doi: 10.1016/j.ijpharm.2004.12.018, PMID 15778052

Katore GS, Bidkar SJ, Dama GY. Formulation and evaluation of ciprofloxacin solid dispersion controlled release floating capsules for solubility improvement. Indian J Pharm Biol Res 2017;5:7-16.

Rahman Z, Zidan AS, Khan MA. Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluation. Int J Pharm 2010;400:49-58. doi: 10.1016/j. ijpharm.2010.08.025, PMID 20801200

Sakure K, Kumari L, Badwaik H. Development and evaluation of solid dispersion based rapid disintegrating tablets of poorly water-soluble anti-diabetic drug. J Drug Deliv Sci Technol 2020;60:2-29. doi: 10.1016/j.jddst.2020.101942

Chae JS, Chae BR, Shin DJ, Goo YT, Lee ES, Yoon HY, et al. Tablet formulation of a polymeric solid dispersion containing amorphous alkalinized telmisartan. AAPS PharmSciTech 2018;19:2990-9. doi: 10.1208/s12249-018-1124-y, PMID 30043191

Das PS, Verma S, Saha P. Fast dissolving tablet using solid dispersion technique: A review. Int J Curr Pharm Res 2017;9:1-4. doi: 10.22159/ ijcpr.2017v9i6.23435

Varma MM, Kumar PS. Formulation and evaluation of gliclazide tablets containing PVP-K30 and hydroxypropyl-β-cyclodextrin solid dispersion. Int J Pharm Sci Nanotechnol 2012;5:1706-19.

Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 2006;7:E55. doi: 10.1208/pt070255, PMID 16796372

Raj AR, Das AC, Sreerekha S, Harindran J. Formulation and evaluation of verapamil solid dispersion tablets for solubility enhancement. J Pharm Sci 2016;7:39-54.

Madhok S, Madhok A. Enhancement of solubility and dissolution of carvedilol by solid dispersion technique using rota-evaporation and lyophilization methods. Int J Drug Res Tech 2015;5:81-102.

Rewar S, Bansal BK, Singh CJ, Sharma AK. Preparation and evaluation of eprosartan mesylate solid dispersions. Elixir Pharm 2015;80:30810-4.

Shah M, Patel D. Design and evaluation of fast dissolving tablet containing tadalafil solid dispersion. Crit Rev 2020;7:579-82.

Sapkal S, Babhulkar M, Rathi A, Mehetre G, Narkhede M. An overview on the mechanisms of solubility and dissolution rate enhancement in solid dispersion. Int J Pharm Tech Res 2013;5:31-9.

Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. Int J Pharm Sci Rev Res 2010;5:41-51.

Kesarwani P, Rastogi S, Bhalla V, Arora V. Solubility enhancement of poorly water-soluble drugs: A review. Int J Pharm Sci Res 2014;5:3123-7.

Das A, Nayak AK, Mohanty B, Panda S. Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. ISRN Pharm 2011;2011:819765. doi: 10.5402/2011/819765, PMID 22389861

Saharan VA, Kukka V, Kataria M, Gera M, Choudhury PK. Dissolution enhancement of drugs Part II: Effect of carriers. Int J Health Res 2009;2:207-23. doi: 10.4314/ijhr.v2i3.47904

Kanikkannan N. Technologies to improve the solubility, dissolution, and bioavailability of poorly soluble drugs. J Anal Pharm Res 2018;7:44-50.

Manna S, Kollabathula J. Formulation and evaluation of ibuprofen controlled release matrix tablets using its solid dispersion. Int J Appl Pharm 2019;11:71-6. doi: 10.22159/ijap.2019v11i2.30503

McFall H, Sarabu S, Shankar V, Bandari S, Murthy SN, Kolter K, et al. Formulation of aripiprazole loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. Int J Pharm 2019;554:302-11. doi: 10.1016/j.ijpharm.2018.11.005, PMID 30395959

Isobe N, Noguchi K, Nishiyama Y, Kimura S, Wada M, Kuga S. Role of urea in alkaline dissolution of cellulose. Cellulose 2013;20:97-103. doi: 10.1007/s10570-012-9800-7

Gunnarsson M, Hasani M, Bernin D. Influence of urea on methyl β-D-glucopyranoside in alkali at different temperatures. Cellulose 2019;26:9413-22. doi: 10.1007/s10570-019-02730-4

Shah M, Patel D. Development and characterization of tadalafil solid dispersion using skimmed milk for improved the solubility and dissolution release profile. J Pharm Technol 2020;13:6212-7. doi: 10.5958/0974-360X.2020.01083.5

Arali B, Kumar AY, Setty CM. An approach to enhance dissolution rate of rilpivirine by solid dispersion technique. J Pharm Sci Res 2019;11:3145-52.

Shah M, Patel D. Development of an oxcarbazepine solid dispersion using skimmed milk to improve the solubility and dissolution profile. Int J Pharm Sci Drug Res 2019;11:204-9. doi: 10.25004/ IJPSDR.2019.110509

Verma P, Ahuja M, Bhatia M. Novel binary itraconazole-skimmed milk solid dispersion: Preparation and evaluation. Pharm Lett 2016;8:55-64.

Bindhani S, Mohapatra S. Recent approaches of solid dispersion: A new concept towards oral bioavailability. Asian J Pharm Clin Res 2018;11:72-8.

Sumaiyah S, Mentari J, Suryanto S. The effect of crospovidone on the dissolution profile of amlodipine besylate from fast orally dissolving film. Open Access Maced J Med Sci 2019;7:3811-5. doi: 10.3889/ oamjms.2019.510, PMID 32127982

Tamboli JA, Mohite SK. Immediate release solid dispersion tablet of azilsartan: Formulation strategy to enhance oral bioavailability. Int J Appl Pharm 2020;12126-34. doi: 10.22159/ijap.2020v12i4.37695

Palmieri A, Dimmer C, Groben W, Jukka R. Dissolution of suppositories IV: Effect of crospovidone on aspirin release from peg bases. Drug Dev Ind Pharm 1984;10:137-56. doi: 10.3109/03639048409038298

Elmubarak EH, Osman ZA, Rahman MA. Formulation and evaluation of solid dispersion tablets of furosemide using polyvinylpyrrolidone K-30. Int J Curr Pharm Res 2021;13:43-50.

Published

07-09-2022

How to Cite

SARKAR, P., and S. BISWAS MAJEE. “FORMULATION DEVELOPMENT AND IN VITRO CHARACTERIZATION OF TERNARY HYDROTROPIC SOLID DISPERSIONS OF ACECLOFENAC”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 9, Sept. 2022, pp. 174-9, doi:10.22159/ajpcr.2022.v15i9.45158.

Issue

Section

Original Article(s)